What is the treatment for sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Sinusitis

Distinguish Viral from Bacterial Sinusitis First

Most cases of acute rhinosinusitis (98-99.5%) are viral and resolve spontaneously within 7-10 days without antibiotics—reserve antibiotics only for confirmed bacterial sinusitis. 1, 2

Diagnose acute bacterial sinusitis when symptoms meet one of three specific patterns: 1, 2

  • Persistent symptoms ≥10 days without clinical improvement
  • Severe symptoms (fever ≥39°C with purulent nasal discharge and facial pain) for ≥3 consecutive days
  • "Double sickening" - worsening symptoms after initial improvement from a viral upper respiratory infection

First-Line Antibiotic Treatment for Acute Bacterial Sinusitis

Amoxicillin remains the first-line antibiotic for uncomplicated acute bacterial sinusitis in both adults and children. 1, 2

Adult Dosing:

  • Mild disease: 500 mg twice daily for 10-14 days 1, 3
  • Moderate disease or high-resistance areas: 875 mg twice daily for 10-14 days 1, 3

Pediatric Dosing:

  • Standard therapy: 45 mg/kg/day in 2 divided doses 3
  • High-dose therapy (age <2 years, daycare attendance, recent antibiotic use, or high-resistance areas): 80-90 mg/kg/day in 2 divided doses 1, 3

Treatment duration should continue until symptom-free for 7 days, typically 10-14 days total. 2, 3

Second-Line Treatment for Antibiotic Failure

If no improvement occurs after 3-5 days of initial amoxicillin therapy, switch to high-dose amoxicillin-clavulanate. 4, 3

  • Adults: 875 mg/125 mg twice daily 3
  • Children: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1, 3

The clavulanate component provides essential coverage against β-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis, which account for treatment failures. 3

For persistent failure after amoxicillin-clavulanate, respiratory fluoroquinolones (levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily for 10 days) provide 90-92% predicted clinical efficacy against drug-resistant organisms. 1, 3

Penicillin-Allergic Patients

For non-severe penicillin allergy (rash, mild reactions), second- or third-generation cephalosporins are safe and effective first-line alternatives. 1, 3

Recommended options include: 4, 3

  • Cefuroxime-axetil (second-generation)
  • Cefpodoxime-proxetil (third-generation)
  • Cefdinir (third-generation)
  • Cefprozil (third-generation)

For severe beta-lactam allergy or true anaphylaxis, use respiratory fluoroquinolones (levofloxacin or moxifloxacin) as first-line therapy. 3

Critical pitfall: Azithromycin and other macrolides should NOT be used due to resistance rates exceeding 20-25% for both S. pneumoniae and H. influenzae. 1, 3

Adjunctive Therapies (Use in ALL Patients)

Intranasal corticosteroids are strongly recommended as adjunctive therapy in both acute and chronic sinusitis to reduce inflammation and improve drainage. 1, 2, 3

  • Fluticasone propionate: 200 mcg/day (two 50-mcg sprays in each nostril once daily) 5
  • Maximum benefit may take several days, though some symptom relief occurs within 12 hours 5
  • Continue for the duration of antibiotic therapy and beyond as needed 4

Additional supportive measures include: 1, 2

  • Analgesics (acetaminophen or NSAIDs) for pain relief
  • Saline nasal irrigation (high-volume daily irrigation for chronic cases)
  • Adequate hydration
  • Warm facial packs
  • Sleeping with head elevated
  • Decongestants (systemic or topical, limited to 3-5 days for topical to avoid rebound)

Chronic Sinusitis Management (Symptoms >8 Weeks)

Chronic sinusitis requires a fundamentally different approach than acute bacterial sinusitis—intranasal corticosteroids become first-line therapy, not antibiotics. 1, 2

Treatment algorithm: 4, 2

  • First-line: Intranasal corticosteroids daily
  • Second-line: Daily high-volume saline irrigation
  • Third-line: Longer duration antibiotic therapy (minimum 3 weeks) only for chronic infectious sinusitis
  • Consider: Short course of systemic corticosteroids or doxycycline for nasal polyps 2

Chronic hyperplastic eosinophilic rhinosinusitis does not respond to antibiotics and may require systemic corticosteroids. 4

When to Refer to a Specialist

Refer patients to an otolaryngologist or allergist-immunologist for: 1, 2

  • Sinusitis refractory to two courses of appropriate antibiotics
  • Recurrent sinusitis (≥3 episodes per year)
  • Suspected complications (orbital cellulitis, meningitis, intracranial involvement)
  • Need to clarify allergic or immunologic basis
  • Chronic sinusitis with nasal polyps after failed medical therapy
  • Anatomical abnormalities requiring surgical evaluation

Patients with recurrent or chronic sinusitis should be evaluated for underlying inflammation, allergic rhinitis, immunodeficiency, and anatomic abnormalities. 4, 3

Critical Pitfalls to Avoid

Do not prescribe antibiotics for viral rhinosinusitis lasting <10 days unless severe symptoms are present—this contributes to antimicrobial resistance without clinical benefit. 1, 6

Never use systemic corticosteroids without antibiotics when bacterial sinusitis is suspected—this may suppress immune response and allow bacterial proliferation. 3

Reassess patients at 72 hours (pediatrics) or 3-5 days (adults)—continuing ineffective therapy beyond this timepoint leads to treatment failure and complications. 3

Reserve fluoroquinolones as second-line therapy—overuse promotes resistance development; use only for treatment failures, complicated sinusitis, or severe penicillin allergy. 1, 3

Complete the full antibiotic course even after symptoms improve—inadequate treatment duration leads to relapse. 2, 3

References

Guideline

Acute Bacterial Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute rhinosinusitis in adults.

American family physician, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.